K vs TCRX · P/E 23, $29.03B cap vs rev $2.0M
Kellanova (K) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
K currently screens at market cap $29.03B and trailing P/E 22.8. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the K and TCRX stock pages for the full models.
Not investment advice.